These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 10595279)

  • 1. Audit of women attending the Aberdeen Genetic Clinic with a family history of breast cancer who subsequently develop cancer.
    Gregory H; Gibbons B; Haites N
    Dis Markers; 1999 Oct; 15(1-3):201-3. PubMed ID: 10595279
    [No Abstract]   [Full Text] [Related]  

  • 2. Breast cancer genetics. Implications of clinical practice.
    Olufunmilayo I; Olopade MD; Fackenthal JD
    Hematol Oncol Clin North Am; 2000 Jun; 14(3):705-25. PubMed ID: 11203330
    [No Abstract]   [Full Text] [Related]  

  • 3. Guidelines for follow-up of women at high risk for inherited breast cancer: consensus statement from the Biomed 2 Demonstration Programme on Inherited Breast Cancer.
    Møller P; Evans G; Haites N; Vasen H; Reis MM; Anderson E; Apold J; Hodgson S; Eccles D; Olsson H; Stoppa-Lyonnet D; Chang-Claude J; Morrison PJ; Bevilacqua G; Heimdal K; Maehle L; Lalloo F; Gregory H; Preece P; Borg A; Nevin NC; Caligo M; Steel CM
    Dis Markers; 1999 Oct; 15(1-3):207-11. PubMed ID: 10595280
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Familial breast and ovarian cancer: genetic counseling and clinical management in Italy.
    Pasini B; Pierotti MA
    Dis Markers; 1999 Oct; 15(1-3):41-3. PubMed ID: 10595250
    [No Abstract]   [Full Text] [Related]  

  • 5. Identification of women at high genetic risk of breast cancer through the National Health Service Breast Screening Programme (NHSBSP).
    de Silva D; Gilbert F; Needham G; Deans H; Turnpenny P; Haites N
    J Med Genet; 1995 Nov; 32(11):862-6. PubMed ID: 8592328
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hereditary susceptibility to breast cancer: significance of age of onset in family history and contribution of BRCA1 and BRCA2.
    Frank TS; Deffenbaugh AM; Hulick M; Gumpper K
    Dis Markers; 1999 Oct; 15(1-3):89-92. PubMed ID: 10595259
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Genetic predisposition for breast cancer: BRCA1 and BRCA2 genes].
    Narod SA; Rodríguez AA
    Salud Publica Mex; 2011; 53(5):420-9. PubMed ID: 22218796
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Breast cancer screening in high-risk women. Rotterdam Committee of Medical and Genetic Counseling.
    Brekelmans CT; Bartels CC; Crepin E; van Geel AN; Meijers-Heijboer H; Seynaeve C; Tilanus-Linthorst MM; Verhoog LC; Wagner A; Klijn JG
    Dis Markers; 1999 Oct; 15(1-3):34-6. PubMed ID: 10595248
    [No Abstract]   [Full Text] [Related]  

  • 9. Efficacy of early diagnosis and treatment in women with a family history of breast cancer. European Familial Breast Cancer Collaborative Group.
    Møller P; Reis MM; Evans G; Vasen H; Haites N; Anderson E; Steel CM; Apold J; Lalloo F; Maehle L; Preece P; Gregory H; Heimdal K
    Dis Markers; 1999 Oct; 15(1-3):179-86. PubMed ID: 10595275
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is p53 a breast cancer gene?
    Polyak K
    Cancer Biol Ther; 2002; 1(1):37-8. PubMed ID: 12197482
    [No Abstract]   [Full Text] [Related]  

  • 11. National Distribution of Cancer Genetic Testing in the United States: Evidence for a Gender Disparity in Hereditary Breast and Ovarian Cancer.
    Childers KK; Maggard-Gibbons M; Macinko J; Childers CP
    JAMA Oncol; 2018 Jun; 4(6):876-879. PubMed ID: 29710084
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Costs and benefits of diagnosing familial breast cancer.
    Heimdal K; Maehle L; Møller P
    Dis Markers; 1999 Oct; 15(1-3):167-73. PubMed ID: 10595273
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management of women at high risk of hereditary breast cancer in the Veneto Regional Program for Prevention.
    Del Sole A; Cinquetti S; Fedato C; Montagna M; Russo F; Sbrogiò LG; Zorzi M
    Epidemiol Prev; 2015; 39(4 Suppl 1):99-101. PubMed ID: 26499424
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of bilateral prophylactic mastectomy (BPMX) in women at high risk of breast cancer.
    Baildam AD
    Dis Markers; 1999 Oct; 15(1-3):197-8. PubMed ID: 10595278
    [No Abstract]   [Full Text] [Related]  

  • 15. New screening techniques for breast cancer (MRI).
    Gilbert FJ
    Dis Markers; 1999 Oct; 15(1-3):115-6. PubMed ID: 10595263
    [No Abstract]   [Full Text] [Related]  

  • 16. Hereditary ovarian carcinoma.
    Gallion HH; Smith SA
    Semin Surg Oncol; 1994; 10(4):249-54. PubMed ID: 8091066
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management of hereditary breast cancer. European Familial Breast Cancer Collaborative Group.
    Eccles DM; Simmonds P; Goddard J; Coultas M; Lalloo F; Evans G; Haites N
    Dis Markers; 1999 Oct; 15(1-3):187-9. PubMed ID: 10595276
    [No Abstract]   [Full Text] [Related]  

  • 18. Cancer screening and risk-reducing behaviors of women seeking genetic cancer risk assessment for breast and ovarian cancers.
    MacDonald DJ; Sarna L; Uman GC; Grant M; Weitzel JN
    Oncol Nurs Forum; 2006 Nov; 33(2):E27-35. PubMed ID: 16518435
    [TBL] [Abstract][Full Text] [Related]  

  • 19. BRCA1 1675delA and 1135insA account for one third of Norwegian familial breast-ovarian cancer and are associated with later disease onset than less frequent mutations.
    Borg A; Dørum A; Heimdal K; Maehle L; Hovig E; Møller P
    Dis Markers; 1999 Oct; 15(1-3):79-84. PubMed ID: 10595257
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular cancer genetics in eastern and central Europe.
    Olah E
    Dis Markers; 1999 Oct; 15(1-3):75-7. PubMed ID: 10595256
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.